🎤 Oral
Immunology and Vaccinology
2022
IV-28
Benchmarking Of The Immune Response Induced By Commercial Intranasal Vaccines Against Brsv In Dairy Calves
Gilles Foucras et al.
Malakoff, France.
Objectives: BRSV is a main respiratory agent in young calves. The intranasal vaccine Rispoval® Intranasal RS+PI3 (Zoetis) is available for more than ten years and has a long history of protective effects in bov
🎤 Oral
Immunology and Vaccinology
2022
IV-29
Influence Of Vaccination On The Seroconversion Of 2 Major Respiratory Pathogens In German Beef Rearing Farms
Egon Thesing et al.
Germany
Objectives: An important part of the German beef sector is the fattening of Simmental/crossbreed bulls. BRD (Bovine Respiratory Disease) is the main health problem on those farms. The causes are multifactorial,
🎤 Oral
Immunology and Vaccinology
2022
IV-30
Impact Of Prepartum Administration Of An Infectious Calf Diarrhea Vaccine On Nonspecific Colostral Immunoglobulin Concentrations Of Dairy Cows
Greg Chambers et al.
Cuttance1. VetEnt Research, Te Awamutu, New Zealand
Objectives: Passive transfer of colostral immunoglobulins from the cow to the calf is essential for calf health. The objec- tive of this study was to determine if prepartum administration of a vaccine stimulate
🎤 Oral
Immunology and Vaccinology
2022
IV-31
Bovine Myeloid Antimicrobial Peptide-28 (Bmap-28) Mrna Expression By Bovine Cells And Effects Of Synthetic Bmap-28 On Bovine Respiratory Disease Pathogens.
Santiago Cornejo Tonnelier et al.
Daryll Vanover2, Hannah Peck2, Philip Santangelo2, Amelia Woolums1. Department of Pathobiology and Population Medicine, College of Veterinary Medicine, Mississippi State University., Mississippi Sta MS, United States
Objectives: Mannheimia haemolytica (MH) is the prin- cipal bacterial pathogen associated with bovine respiratory disease (BRD) in cattle. Bovine Herpes virus type 1 (BHV-1) can cause BRD by itself or it can be
🎤 Oral
Immunology and Vaccinology
2022
IV-32
Q Fever: Vaccinate As Much As Needed And As Little As Possible
Jens Böttcher et al.
Dautzenberg1, Elisabeth Deckinger1, Michaela Alex1, Vanessa Turowski1, Britta Janowetz1. Bavarian Animal Health Service, Poing, Germany
Objective: Coxiella (C.) burnetii is a zoonotic pathogen. Endemic infection in dairy cow farms is frequently observed. A vaccine (CoxevacTM, Ceva Santé Animal) is available to control infection in cattle. In th
🎤 Oral
Immunology and Vaccinology
2022
IV-33
Duration Of Immunity After A Natural Infection With Bovine Respiratory Syncytial Virus
Sara Hägglund et al.
Sabine Riffault4, Geraldine Taylor5, María Jose Rodriguez6, Marga Garcia Duran6, Jean François Valarcher1. Swedish University of Agricultural Sciences, Dept. of Clinical Sciences, Unit of Ruminant Medicine, Host Pathogen Interaction Group, Uppsala, S
Objectives: Bovine respiratory syncytial virus (BRSV) infections commonly occur as epizootic outbreaks in nearby cattle herds. In parallel with improved biosecurity, the main- tenance of herd immunity could con
🎤 Oral
Immunology and Vaccinology
2022
IV-34
Virus Detection By Pcr Following Vaccination Of Naive Calves With Intranasal Or Injectable Multivalent Modified- Live Viral Vaccines
Victor Cortese et al.
2 2 Riddell2, Daniel W. Scruggs3. Zoetis, Simpsonville, United States
Objective: To evaluate the duration and cycle times of PCR-positive results following administration of modified-live viral (MLV) vaccines to sero-negative beef calves. Materials and Methods: Twenty beef calves
🎤 Oral
Immunology and Vaccinology
2022
IV-35
Efficacy Of A Vaccine To Control Coxiellosis In Goats 1 Year After Primo-Vaccination: Assessment Of The Duration Of Immunity
Philippe Gisbert et al.
Orszagh2. Ceva Santé Animale, Libourne, France
Objectives: In small ruminants, Coxiellosis also named Q fever is responsible for abortion, stillbirth and weak born. In addition, Q fever is a zoonosis which can cause flu-like syn- dromes in humans but also a
🎤 Oral
Immunology and Vaccinology
2022
IV-36
A Field Study Evaluating Humoral Immune Response In Calves Vaccinated With Two Multivalent Respiratory Vaccines
Anna Catharina Berge et al.
Vertenten4. Berge Veterinary Consulting BV, Vollezele, Belgium
Objectives: Calf vaccination may be adversely affected by maternal antibodies. Two trivalent inactivated Bovine Respira- tory Disease (BRD) vaccines that are commercialized in Eu- rope (Bovilis® Bovipast RSP or
🎤 Oral
Immunology and Vaccinology
2022
IV-37
Concurrent Vaccination For Pneumonia In Pre-Weaned Calves; A Longitudinal Study On The Safety, And Serological Response Elicited By Delivery Of Two Live Intranasal Vaccines
Anna Flynn et al.
Grassland Science Research Department, Animal & Grassland Research and Innovation Centre, Teagasc Moorepark, Cork, Republic of Ireland
Objectives: Bovine respiratory disease complex (BRD) is an economically important disease with a high mortality rate. In Ireland, it remains the leading cause of death in calves be- tween 1 and 12 months of age
🖼️ Poster
Immunology and Vaccinology
2022
IV-P03
Nine-Week Duration Of Immunity Against A Virulent Mannheimia Haemolytica Challenge In 60-Day-Old Calves Vaccinated With A Multivalent Vaccine Containing A M. Haemolytica Toxoid
Veronique Moulin et al.
Nancee Oien1. Zoetis Inc, Kalamazoo, MI, United States
Bovine respiratory disease complex (BRDC) is one of the most important health problems in the cattle industry. One of the major bacterial causative agents of BRDC is Mannheimia haemolytica which causes disease
🖼️ Poster
Immunology and Vaccinology
2022
IV-P04
Efficacy Of The Intranasal Respiratory Vaccine Against Ibrv, Pi3V, And Brsv In Early Weaned Calves
Doo Kim et al.
College of Veterinary Medicine / Kangwon National University, Chuncheon, Kangwon, South Korea.
Objectives: Bovine respiratory disease (BRD) is a one of the most money costing disease in bovine production. Farm- ers usually use commercial vaccines which are modified live or killed vaccines around weaning
🖼️ Poster
Immunology and Vaccinology
2022
IV-P05
Case Study Report: Less Individual Antibiotic Treatments After Intranasal Vaccination Against Respiratory Viruses In Rose Veal Calves
Monique Driesse et al.
Netherlands
Objectives: The objective of this case study was to evalu- ate whether vaccination against Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza 3 (PI3) on a rose veal farm resulted in less individual ant
🖼️ Poster
Immunology and Vaccinology
2022
IV-P06
Comparison Of Milk Production Of Dairy Cows Vaccinated With A Live Double Deleted Bvdv Vaccine And Non-Vaccinated Dairy Cows Cohabitating In Endemic Bvdv Herds
Ellen Schmitt-Van De Leemput et al.
Objective: Daily milk production and reproductive perfor- mance of cows vaccinated with a live double-deleted Bovine viral diarrhoea virus (BVDV) vaccine were compared to those of non-vaccinated animals, cohabitating in endemic BVD herds.
Materials & methods: All animals in the treatment group were vaccinated at a single point in time (day 0) irrespective of lactation or gestation status, while control animals did not receive any treatment. The
🖼️ Poster
Immunology and Vaccinology
2022
IV-P07
Spot Testing In Multiple Vaccinated Herds With A Live Bvdv Vaccine In The Netherlands
Monique Driesse et al.
Netherlands
Objectives: In many countries spot testing of young stock is an applied method to monitor the BVD status of herds. In the Netherlands a mandatory BVD control program for dairy farms is in place since April 2018
🖼️ Poster
Immunology and Vaccinology
2022
IV-P08
Bvd Antibody Testing In Young Stock From 6 Months Of Age In Herds Vaccinated With A Live Bvdv Vaccine
Monique Driesse et al.
Netherlands
Objectives: BVD vaccination, especially with live vac- cines, leads to the development of BVD p80 antibodies and the presence of maternally derived antibodies after colostrum uptake in their offspring. This cou
🖼️ Poster
Immunology and Vaccinology
2022
IV-P09
Q Fever: Development And Persistence Of Phase-Specific Antibodies In Individual Milk Samples After Vaccination
Ann-Sophie Kraus et al.
Freising, Freising-Pulling, Germany.
Objective: Coxiella (C.) burnetii is classified as a zoonotic pathogen. Small ruminants are regarded as a major source of human infection; however, the pathogen is frequently detect- ed in dairy cattle farms, t
🖼️ Poster
Immunology and Vaccinology
2022
IV-P10
Combined Approach Of Vaccination With Test & Cull Of Persistently Infected Animals Delivered Successful Control Of Bovine Viral Diarrhea (Bvd) – A Field Experience
Giorgio Valla et al.
Ceva Santé Animale, Libourne, France.
Objectives: Bovine viral diarrhea virus (BVDV) is a diverse group of viruses responsible for causing disease in ruminants worldwide. Infection by BVDV leads to substantial costs for cattle producers through dec
🖼️ Poster
Immunology and Vaccinology
2022
IV-P11
Interest Of Clostridial Vaccination In Pregnant Cows To Reduce Omphalitis In Beef Calves. Results From A Field Study In France
Philippe Gisbert et al.
Besbre, France
Objectives: Several French practitioners reported that the proportion of calves with omphalitis was lower in beef herds that vaccinate pregnant cows against clostridial disease com- pared to herds that does not
🖼️ Poster
Immunology and Vaccinology
2022
IV-P12
Evaluation Of Immunogenicity Of An Inactivated Korean Les Bovine Viral Diarrhea Virus 1A And 2A Vaccine In Calves R Against Virulent Viral Challenge Nce.
Bang-Hun Hyun et al.
An. Animal and Plant Quarantine Agency, Gimcheon, South Korea.
Objectives: Bovine viral diarrhea virus (BVDV) 1a and 2a strains are the predominant sub-genotypes in South Korea. Because of the genetic and antigenic variability among differ- ent BVDV strains, multivalent va
🖼️ Poster
Immunology and Vaccinology
2022
IV-P13
Efficacy Of Inactivated Ge-Deleted Marker Vaccines Against Bovine Alphaherpesvirus 1 (Bohv-1) In Pregnant Cattle To Evaluate Passive Immunity
Stefano Petrini et al.
Gian Mario De Mia1. National Reference Laboratory for Infectious Bovine Rhinotracheiti (IBR), Istituto Zooprofilattico Sperimentale Umbria-Marche “Togo Rosati”, Perugia, Italy
Objectives: Bovine alphaherpesvirus 1 (BoHV-1) is a member of the subfamily Alphaherpesvirinae and is responsi- ble for significant economic losses in the cattle industry world- wide. The virus causes a variety
🖼️ Poster
Immunology and Vaccinology
2022
IV-P14
A New Live Attenuated Brsv Vaccine Triggers Both Local And Systemic Cellular Immune Responses In Newborn Calves After Intranasal Administration
Maria Carmen Moreno et al.
HIPRA, Amer, Spain.
Objectives: A new vaccine (NASYM®) that reduces re- spiratory clinical signs and Bovine Respiratory Syncytial Vi- rus (BRSV) shedding has recently been registered. One of the most important features of this new
🖼️ Poster
Immunology and Vaccinology
2022
IV-P15
A New Live Attenuated Brsv Vaccine Triggers Both Humoral And Cellular Immune Responses In Young Calves Of 10 Weeks Of Age After Intramuscular Administration
Elena Marzo et al.
HIPRA, Amer, Spain.
Objectives: The main goal of this work was to character- ise the immune response triggered by a live attenuated BRSV vaccine (NASYM®) after intramuscular administration in young calves. Materials and methods: T
🖼️ Poster
Immunology and Vaccinology
2022
IV-P16
A Clear Decline In Antibiotic Use And Mortality Rate On A Veal Calf Farm In Belgium After Implementing A Brd Vaccination Protocol
Pieter De Wolf et al.
Veterinary Clinic Venhei, Kasterlee, Belgium
Objectives: A BRD vaccination protocol was implemented on a veal calf farm in Belgium due to periodic, recurrent re- spiratory problems. This enabled different parameters of the fattening period, in which vacci